Picture of Corline Biomedical AB logo

CLBIO — Corline Biomedical AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Corline Biomedical Q4 Operating Loss Widens To SEK 2.1 Mln

Feb 25 (Reuters) - Corline Biomedical AB  CLBIO.ST :
    * Q4 NET SALES SEK 0.4 MILLION VERSUS SEK 0.5 MILLION YEAR
AGO
    * Q4 OPERATING LOSS SEK 2.1 MILLION VERSUS LOSS SEK 1.7
MILLION
YEAR AGO

Source text for Eikon:  ID:nGNE20dL3B 
Further company coverage:  CLBIO.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Corline Biomedical AB

See all news